Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Report 2026

Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Overview

• Specific Immunoglobulin G Subclass 4 (IgG4) Testing market size has reached to $1.37 billion in 2025 • Expected to grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Increasing Prevalence Of Allergic Diseases Fueling The Growth Of The Market Amid Growing Demand For Accurate Allergy Assessment • Market Trend: Advancements in High-Performance Immunoassay Systems Enhancing Workflow Optimization and Clinical Decision-Making • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

Specific immunoglobulin G subclass 4 (IgG4) testing measures the level of IgG4, one of the antibodies that the body produces as part of its immune defense. In this test, a blood sample is analyzed to determine how much IgG4 is present, since unusually high levels may point to abnormal immune activity. The results help clinicians evaluate conditions such as IgG4-related disease and better understand certain immune or inflammatory responses. The main product types of specific immunoglobulin G subclass 4 (IgG4) testing include reagents and kits, instruments, and services. Reagents and kits are pre-packaged chemical or biological materials designed to facilitate the accurate detection, measurement, or analysis of specific targets in diagnostic testing. The key applications are allergy diagnosis, autoimmune disease diagnosis, research, and others, and they are used by several end-users, such as hospitals and clinics, diagnostic laboratories, research institutes, and others.

What Is The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Growth Forecast?

The specific immunoglobulin g subclass 4 (igg4) testing market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of hospital-based testing facilities, growing investments in laboratory automation, rising adoption of advanced immunology panels, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of specialized immunoassays, rising demand for autoimmune disease diagnostics, growing use of igg4 testing in clinical practice, expansion of laboratory automation in immunology, enhanced focus on diagnostic accuracy.

Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Segmentation

1) By Product Type: Reagents And Kits, Instruments, Services 2) By Application: Allergy Diagnosis, Autoimmune Disease Diagnosis, Research, Other Applications 3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users Subsegments: 1) By Reagents And Kits: Purification Reagents, Detection Reagents, Assay Kits, Calibrators, Controls 2) By Instruments: Automated Analyzers, Enzyme Linked Immunoassay Readers, Microplate Washers, Sample Preparation Systems, Laboratory Automation Platforms 3) By Services: Testing Services, Validation Services, Quality Assurance Services, Custom Assay Development Services, Technical Support Services

What Is The Driver Of The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

The increasing prevalence of allergic diseases is expected to propel the growth of the specific immunoglobulin G subclass 4 (IgG4) testing market going forward. Allergic diseases refer to immune-mediated hypersensitivity disorders such as food allergies, atopic dermatitis, asthma, and allergic rhinitis, which occur when the immune system reacts abnormally to usually harmless substances. The prevalence of allergic diseases is rising due to changes in dietary patterns, as increased consumption of highly processed foods can alter gut microbiota and elevate the likelihood of developing allergic sensitization. Specific IgG4 testing helps assess immune responses linked to repeated allergen exposure, supporting clinicians in understanding tolerance patterns and interpreting complex allergy-related immune activity. For instance, in May 2024, according to the Food Standards Agency (FSA), a UK-based government body responsible for food safety and public health protection, around 6%, or 2.4 million, of the UK adult population was found to have a clinically confirmed food allergy. Therefore, the increasing prevalence of allergic diseases is driving the growth of the specific immunoglobulin G subclass 4 (IgG4) testing industry.

Key Players In The Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market

Major companies operating in the specific immunoglobulin g subclass 4 (igg4) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Revvity, Randox Laboratories Ltd, NeoGenomics Laboratories Inc., ARUP Laboratories, Dr Lal PathLabs Limited, Metropolis Healthcare Ltd, ProSci Incorporated, Leinco Technologies Incorporated, MyBioSource Inc., Boster Biological Technology, PROTIA Inc., Creative Diagnostics LLC.

Global Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Trends and Insights

Major companies operating in the specific immunoglobulin G subclass 4 (IgG4) testing market are focusing on incorporating innovation in testing platforms and methodologies, such as high-sensitivity immunoassay technology, to enhance assay accuracy, analytical performance, and diagnostic reliability. High-sensitivity immunoassays are advanced detection systems that use optimized antibodies, enhanced signal generation chemistries, and refined assay workflows to quantify very low analyte concentrations with high precision, enabling capabilities such as improved detection limits, superior specificity, and consistent result reproducibility. For instance, in September 2025, Alta DiagnoTech, a US-based developer of IVD immunoassay solutions, launched its ELISA Kits for IVD Immunology Testing, a high-sensitivity immunoassay-based product line designed for accurate biomarker quantification across a broad range of immunological applications. The kits feature enhanced assay sensitivity, strong manufacturing stability, and broad applicability in immunology test workflows. This platform improves test reliability, analytical precision, and overall diagnostic confidence in immunology testing settings.

What Are Latest Mergers And Acquisitions In The Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

In December 2023, Danaher Corporation, a US-based provider of life sciences, diagnostics, and biotechnology solutions, acquired Abcam plc for $5.7 billion. With this acquisition, Danaher gains access to Abcam’s extensive portfolio of antibodies, recombinant proteins, assay kits, and immunoassay reagents, thereby enhancing its specialized immunodiagnostic capabilities, including those supporting specific IgG4 testing workflows, while improving its global research infrastructure, operational scale, and customer reach. Abcam plc is a UK-based provider of high-quality biological reagents and research assay solutions and is known for its strong expertise in antibody development and standardized ELISA platforms, including research-grade IgG4-specific tools used widely in immunology and biomarker research.

Regional Outlook

North America was the largest region in the specific immunoglobulin G subclass 4 (IgG4) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market?

The specific immunoglobulin G subclass 4 (IgG4) testing market includes revenues earned by entities by providing services such as sample collection services, specimen transport services, pre-analytical preparation services, data management services, clinical consultation services, and results dissemination services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Report 2026?

The specific immunoglobulin g subclass 4 (igg4) testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the specific immunoglobulin g subclass 4 (igg4) testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.